![]() Ssusan Forte O'Neill Barbara Marsh, Los Angeles Times Philip Beaudon, American Electronics Association Congressman Christopher Cox |
![]() Congressman Christopher Cox Dr. David Gollaher, California Healthcare Institute Christopher Noler, Price Waterhouse LLP |
![]() James LoPresti, Price Waterhouse LLP Henry Riggs, Keck Graduate Institute of Applied Sciences |
|
In 1997 and beyond the market for new medical innovations will be defined by state and federal policy -- intellectual property protection, securities law, the FDA approval process, Medicare and Medicaid payment policy, tax incentives, and scientific research funding. Actions taken today by legislators have never been more important to the future growth and prosperity of California's biotechnology, pharmaceutical and medical device industries.
|
|
Speaker Date: August 7,
1996 |
Jon
Dudas Counsel to the House Subcommittee on Courts and Intellectual Property Date August 21, 1996 Location: Hyatt Regency La Jolla |
|
Assembly Majority
Leader Date: September
18, 1996 |
Congressman Date:October 22,
1996 |
|
Senate President
Pro Tempore Date: October 23,
1996 |
State Treasurer
Date: March 12,
1997 |